These results indicate that KLF5 may be utilized as a diagnostic tool for cancer, a predictor of its progression, and a guide for treatment., with particular promise as a therapeutic target for glioma and bladder cancer. This evidence concerns the gene KLF5 and urinary bladder carcinoma.